Skip to content

邦吉

US · BG #907 按市值排名 上市于 1970
106.14 -0.87 -0.81%
实时 - 追踪5344个代码 - 心跳于417秒前 · 2026-10-16 20:02

✦ 量化合理价值 计算方式说明

高于合理价值
23.37 合理价值 ≈ 55.85 88.34
  • 基于该股自身过去5年平均市盈率乘以滚动每股收益,推算出的合理价值区间为23.37-88.34。
  • 当前价格比按平均倍数计算的合理价值(55.85)高90.0%。

估值 各估值倍数与自身5年区间的对比

市净率 1.24 低于历史水平 第17百分位
5年平均 1.49 · 在Farm Products中排名第11/19
市盈率 22.24 高于历史水平 第86百分位
5年平均 11.38 · 前瞻 9.96 · 在Farm Products中排名第6/11
市销率 0.21 低于历史水平 第20百分位
5年平均 0.25 · 前瞻 0.21 · 在Farm Products中排名第8/25

同业对比 Farm Products

公司 市值 市盈率(TTM) 市净率 股息率
邦吉 (BG) 20.39B 22.97 1.28 2.66%
Archer Daniels Midland (ADM) 39.81B 22.57 1.69 2.49%
Tyson Foods (TSN) 19.31B 33.89 1.07 3.70%
Smithfield Foods (SFD) 7.34B 6.93 1.05 6.04%
Cal-Maine Foods (CALM) 2.97B 50.92 1.16 3.85%
CHS INC CUM RED PRF 'B' USD25 (CHSCO) 1.98B 0.00 0.32 0.00%

StockVane 追踪范围内同行业的其他公司。

Morningstar

★★★☆☆ 合理价值113.25 经济护城河None 不确定性Medium

当前股价低于晨星合理价值估算6.7%。

合理价值

Bunge Global SA receives a 3-star quantitative star rating, reflecting our opinion that this share class is a balanced choice, but prudent investors should consider looking elsewhere. The stock currently trades at a 9% discount to our quantitative fair value estimate of $113.25 per share; however, some caution is warranted due to this estimate's medium uncertainty rating. We require the price/fair value ratio to move a certain amount before the star rating can change. This stability-enhancing buffer is in effect for this stock.

The company's valuation metrics strengthen our estimated fair value. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. Reflecting the firm's valuation is its book value yield of 77.8%, which lies in the top 40% globally. The market price is low relative to the book (accounting) value of the company's equity, which contributes to our view that shares are undervalued.

The company's balance sheet is an additional encouraging factor. Leverage can enable a company to invest in growth, potentially boosting shareholder value more than equity financing alone. The firm's EBITDA/interest coverage ratio of 3.7, a core component of leverage, lies in the bottom 30% compared with global peers. Although the firm's ability to cover interest payments with EBITDA is limited, shares could sharply rebound if economic circumstances change or recent investments reduce fears of default. This characteristic further promotes our favorable price/fair value ratio.

In addition to the aforementioned drivers, our model considers momentum as part of its comprehensive analysis. This share class has outperformed the broader universe over the past year. While we believe the stock is undervalued, this outperformance had a negative impact on our valuation estimate.

经济护城河

With its quantitative economic moat rating of none, we do not expect this company to materially outearn its cost of capital in the long run. Additionally, the firm's moderate financial health score suggests it is acceptably positioned against adverse economic circumstances.

作者:Quantitative Equity Report

报价时间 2026-10-16 20:02:29 · 仅供参考,不构成投资建议,也未考虑您的具体情况。

邦吉 讨论区 0 条评论

发表评论